- Home
- TYG vs QDEL Comparison
TYG vs QDEL Comparison
Compare TYG & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TYG | QDEL |
|---|---|---|
| Founded | 2003 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2003 | 2022 |
Fundamental Metrics
Financial Performance| Metric | TYG | QDEL |
|---|---|---|
| Price | $46.44 | $10.81 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $28.25 |
| AVG Volume (30 Days) | 83.6K | ★ 2.9M |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | ★ 11.71% | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | N/A | $3.51 |
| Revenue Next Year | N/A | $3.86 |
| P/E Ratio | $52.62 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $39.93 | $10.21 |
| 52 Week High | $51.18 | $35.58 |
Technical Indicators
Market Signals| Indicator | TYG | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 37.39 | 34.51 |
| Support Level | $42.25 | N/A |
| Resistance Level | $48.99 | $17.78 |
| Average True Range (ATR) | 0.91 | 0.93 |
| MACD | -0.10 | 0.07 |
| Stochastic Oscillator | 1.63 | 18.14 |
Price Performance
Historical ComparisonAbout TYG Tortoise Energy Infrastructure Corporation
Tortoise Energy Infrastructure Corp seeks to provide a high level of current income to stockholders. It invests in fixed-income and dividend-paying equity securities of power and energy infrastructure companies that provide stable and defensive characteristics throughout economic cycles.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.